Fig. 2From: Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogsScatter plots representing the distribution of (A) blood urea nitrogen (BUN), (B) creatinine, (C) alanine aminotransferase (ALT), and (D) Alkaline phosphatase (ALKP) including the median and interquartile range of each parameter in dogs with MMVD stage C at the baseline and after treatment with a combination of pimobendan, furosemide, and enalapril at 1 (M1), 3 (M3), and 6 (M6) months; the central horizontal bar in each column represents the median. The error bars represent the 1st and 3rd quartilesBack to article page